BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Vistagen Receives FDA “Study May Proceed” Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause

  April 23, 2026

   · 

  7 min read
• Press Releases

  Sarepta Therapeutics to Announce First Quarter 2026 Financial Results

  April 23, 2026

   · 

  1 min read
• Press Releases

  Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

  April 23, 2026

   · 

  4 min read
• Press Releases

  Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026

  April 23, 2026

   · 

  5 min read
• Press Releases

  Capricor Therapeutics Announces Late-Breaking Presentation of HOPE-3 Phase 3 Results at the American Academy of Neurology 2026 Annual Meeting

  April 23, 2026

   · 

  6 min read
• Press Releases

  BBOT Announces the Appointment of Pedro J. Beltran, PhD, as Chief Executive Officer, Idan Elmelech as Chief Operating Officer, and Neil Kumar, PhD, as Executive Chairman

  April 23, 2026

   · 

  5 min read
• Press Releases

  Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy at the International Society for Cell & Gene Therapy 2026 Annual Meeting

  April 23, 2026

   · 

  4 min read
• Press Releases

  Sandhills Medical Appoints Amanda Duke as Chief Executive Officer

  April 23, 2026

   · 

  2 min read
• Press Releases

  Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment

  April 23, 2026

   · 

  8 min read
• Press Releases

  Adial Pharmaceuticals Successfully Completes Manufacturing of Demonstration Batch Production, Enabling Clinical and Registration Production for AD04 Planned Phase 3 Trial

  April 23, 2026

   · 

  5 min read